UBS Group AG - BENITEC BIOPHARMA LTD ownership

BENITEC BIOPHARMA LTD's ticker is BNTC and the CUSIP is 082053307. A total of 6 filers reported holding BENITEC BIOPHARMA LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BENITEC BIOPHARMA LTD
ValueSharesWeighting
Q3 2019$4,0000.0%6,009
+6.9%
0.00%
Q2 2019$4,000
+33.3%
5,622
+240.7%
0.00%
Q1 2019$3,000
+200.0%
1,650
+97.1%
0.00%
Q4 2018$1,000
-80.0%
837
-60.5%
0.00%
Q3 2018$5,000
-37.5%
2,117
-43.7%
0.00%
Q2 2018$8,000
-27.3%
3,761
+6.6%
0.00%
Q1 2018$11,000
-15.4%
3,527
-20.6%
0.00%
Q4 2017$13,000
+30.0%
4,443
+2.0%
0.00%
Q3 2017$10,000
+400.0%
4,358
+198.9%
0.00%
Q2 2017$2,000
+100.0%
1,458
+483.2%
0.00%
Q1 2017$1,000250
+1.6%
0.00%
Q4 2016$0246
-29.7%
0.00%
Q3 2016$0
-100.0%
350
-81.9%
0.00%
Q2 2016$2,0001,9360.00%
Other shareholders

There were no reported owners of BENITEC BIOPHARMA LTD in Q4 2017.

NameSharesValueWeighting ↓
View complete list of BENITEC BIOPHARMA LTD shareholders